Identification and assessment of new vaccine candidates for group A streptococcal infections (Q47218040)

11 January 2018

title

Identification and assessment of new vaccine candidates for group A streptococcal infections (English)

1 reference

11 January 2018

author

Mark R. Davies

4

1 reference

11 January 2018

Kadaba Sriprakash

6

1 reference

11 January 2018

author name string

David J McMillan

1

1 reference

11 January 2018

Michael R Batzloff

2

1 reference

11 January 2018

Cindy L Browning

3

1 reference

11 January 2018

Michael F Good

5

1 reference

11 January 2018

Robert Janulczyk

7

1 reference

11 January 2018

Magnus Rasmussen

8

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

11 January 2018

published in

Vaccine

1 reference

11 January 2018

volume

22

1 reference

11 January 2018

issue

21-22

1 reference

11 January 2018

page(s)

2783-2790

1 reference

11 January 2018

Vaccine strategies to prevent rheumatic fever

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Immunogenicity of a 26-valent group A streptococcal vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Pathogenesis of group A streptococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Systemic and mucosal immunizations with fibronectin-binding protein FBP54 induce protective immune responses against Streptococcus pyogenes challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Protective Immune Response againstStreptococcus pyogenesin Mice after Intranasal Vaccination with the Fibronectin‐Binding Protein SfbI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Complete genome sequence of an M1 strain of Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Improved pattern for genome-based screening identifies novel cell wall-attached proteins in gram-positive bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Expert system for predicting protein localization sites in gram-negative bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Immune responses to novel pneumococcal proteins pneumolysin, PspA, PsaA, and CbpA in adenoidal B cells from children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Characterization of a gene coding for a type IIo bacterial IgG-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Isolation and characterization of type IIa and type IIb Fc receptors from a group A streptococcus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

NAD-glycohydrolase production and speA and speC distribution in Group A streptococcus (GAS) isolates do not correlate with severe GAS diseases in the Australian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.043

10.1016/J.VACCINE.2004.01.043

7 January 2021

Identifiers

DOI

1 reference

11 January 2018

1 reference

11 January 2018